Remove 2019 Remove Events Remove Medicine Remove Safety
article thumbnail

GW Pharmaceuticals Pre-Announces Preliminary Unaudited Fourth Quarter and Full-Year 2019 Net Product Sales

Cannabis Law Report

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. 14th at 11:00 a.m.

article thumbnail

New- ANH-Intl Special Report: Is safety the new gremlin for CBD regulation?

Cannabis Law Report

We take a look at where CBD regulation might be going and whether we should be concerned about safety writes Rob Verkerk PhD, scientific and executive director, ANH-Intl. We take a look at where CBD regulation might be going and whether we should be concerned about safety. A new ‘problem’: safety. ? A new ‘problem’: safety.

Safety 59
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Oregon Cannabis: 2019 Legislative Forecast and Report

Canna Law Blog

At this point, over a month into the 2019 session, a preponderance of legislators appear vaguely inclined to “let it ride” and drop the big ideas when it comes to cannabis. Permits for temporary (outdoor) events, on the other hand, might have legs as long as alcohol isn’t present. This should have happened already.

article thumbnail

Interstate Cannabis Agreements in California

Canna Law Blog

I get asked a lot of questions about what California cannabis licensees can and cannot do under the Medicinal and Adult-Use Cannabis Regulation and Safety Act (“MAUCRSA”). Oregon’s New Cannabis Laws: The Definitive List (2019). For example, vertical integration is allowed. So what’s next?

article thumbnail

Six Things You Need to Know About CBD and Other Hemp-containing Pet Products

Cannabis Law Report

In testimony before the US Senate in July 2019, Dr. Amy Abernethy, Principal Deputy Commissioner at FDA, stated that the Agency recognizes the need for “regulatory clarity, particularly given the significant public interest in hemp products, and CBD in particular.” Who’s responsible for regulating CBD in pet products?

Pets 105
article thumbnail

Harvard Is Launching America’s First Psychedelics Law and Policy Center

SpeedWeed

The Project on Psychedelics Law and Regulation (POPLAR) is a three-year project aiming to “promote safety, innovation, and equity in psychedelics research, commerce, and therapeutics,” the university said in a press release. The US market for medicinal psychedelics is predicted to grow to $6.85

Policy 52
article thumbnail

Should U.S. Cannabis Companies Seek Trademark Protection in Canada?

Canna Law Blog

With Canada’s new trademark law set to take effect on June 17, 2019, U.S. cannabis companies should be considering whether it makes sense for them to file for trademark protection in Canada. Furthermore, cannabis goods can be specified in any Canadian trademark application.